510(k) Report

510(k) · Cleared

Cleared

CSMC Cardiac Suite-Nuclear Medicine Software Applicaton Model 2010-01

K100714510(k) TraditionalCleared Apr 1, 2011385-day reviewClass II21 CFR 892.1200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cedars-Sinai Medical Center · KPS System, Tomography, Computed, Emission

Cleared on Apr 1, 2011 as substantially equivalent to K060020 (Adac Laboratories, 2006) and 1 other predicate after a 385-day review. Its family tree reaches back 4 generations to 2000.

Decided
Apr 1, 2011
Review
385 days
Class
Class II
Product code
KPS
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K003264 (2000). 6 ancestors in all, the oldest K980715 (1998). No later device cites it as a predicate yet.

  1. Root · 4 generations backK003264 QPS/BPGS/Moco Processing Applications for Entegra WorkstationGe Medical Systems F.I. Haifa · 2000
  2. 3 generations backK022428 Quantitative Blood Pool Spect (QBS)Adac Laboratories · 2002
  3. 2 generations backK040326 Autoquant PlusAdac Laboratories · 2004
  4. 1 generation backK060020 Autoquant PlusAdac Laboratories · 2006
  5. This deviceK100714 CSMC Cardiac Suite-Nuclear Medicine Software Applicaton Model 2010-01Cedars-Sinai Medical Center · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K003264QPS/BPGS/Moco Processing Applications for Entegra WorkstationGe Medical Systems F.I. Haifa2000—
−3K022428Quantitative Blood Pool Spect (QBS)Adac Laboratories2002—
−2K040326Autoquant PlusAdac Laboratories2004—
−1K060020Autoquant PlusAdac Laboratories2006—
0 (this device)K100714CSMC Cardiac Suite-Nuclear Medicine Software Applicaton Model 2010-01Cedars-Sinai Medical Center2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200110
FIG. 1 — Lineage of K100714, 2000–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPS device

  1. #1 K253564 uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI…score 18.6 · 17 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K060020Autoquant Plus
Summary page 2
…Programs Manufacturer Product Name 510(k) No. ADAC Laboratories AutoQUANTO Plus K060020 GE/SMV America Cedars-Sinai BPGS/MoCo Software Programs K010509 PRODUCT NAME 510(k) CLEARANCE…
Adac Laboratories2006—
*K010509Cedars-Sinai BPGS and Moco
Summary page 2
…510(k) No. ADAC Laboratories AutoQUANTO Plus K060020 GE/SMV America Cedars-Sinai BPGS/MoCo Software Programs K010509 PRODUCT NAME 510(k) CLEARANCE MANUFACTURER ___________NUMBER DATE AutoQU…
Smv America2001—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 3 companies; a new generation was cleared every 1.9 years on median.
  • None of the 6 ancestors has a recall.

How does its category compare?

All KPS devices

KPS System, Tomography, Computed, Emission: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · KPS

12in 2025

2007: 82008: 172009: 92010: 32011: 72012: 62013: 112014: 112015: 32016: 112017: 112018: 132019: 32020: 122021: 152022: 52023: 122024: 112025: 122026 (partial year): 6
2007high 17 (2008) · low 3 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPS

65in 2025

2007: 38 days median2008: 25 days median2009: 42 days median2010: 91 days median2011: 28 days median2012: 94 days median2013: 84 days median2014: 92 days median2015: 112 days median2016: 65 days median2017: 104 days median2018: 59 days median2019: 60 days median2020: 72 days median2021: 66 days median2022: 60 days median2023: 63 days median2024: 59 days median2025: 65 days median2026 (partial year): 67 days median
2007high 112 (2015) · low 25 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPS

16in 2025

2007: 222008: 162009: 142010: 42011: 342012: 132013: 132014: 182015: 52016: 162017: 112018: 12, 3 Class I2019: 5, 5 Class I2020: 82021: 42022: 8, 6 Class I2023: 6, 3 Class I2024: 152025: 162026 (partial year): 6
2007high 34 (2011) · low 4 (2010)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · KPS

36in 2025

2007: 382008: 112009: 152010: 442011: 562012: 342013: 2402014: 332015: 242016: 102017: 312018: 262019: 1052020: 222021: 102022: 152023: 222024: 232025: 36
2007high 240 (2013) · low 10 (2016)2025

MAUDE reports naming product code KPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078382238
200817251611
20099421415
2010391444
20117283456
20126941334
2013118413240
201411921833
20153112524
201611651610
2017111041131
2018135912 (3)26
20193605 (5)105
20201272822
20211566410
20225608 (6)15
202312636 (3)22
202411591523
202512651636
20266676—

What is it indicated for?

The Cedars-Sinai Cardiac Suite of applications is intended to enable an automated display, review, and quantification of Nuclear Medicine Cardiology medical images and datasets. Cedars-Sinai Cardiac Suite may be used in multiple settings including the hospital, clinic, doctors office, or remotely. The results provided should be reviewed by qualified healthcare professionals (e.g., radiologists, cardiologists, or general nuclear medicine physicians) trained in the use of medical imaging devices.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K100714: CSMC Cardiac Suite-Nuclear Medicine Software Applicaton Model 2010-01.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K100714

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026